2024-11-25 19:43:32
Everest Medicines Announces Approval of Clinical Trial Application by China NMPA for Phase 3 Trial of Xerava(TM) for Community-Acquired Bacterial Pneumonia
Corporate/ 2023-07-23
Everest Medicines Announces Approval of ...

SHANGHAI,Aug. 5,2021-- Everest Medicines (HKEX 1952.HK),a biopharmaceutical company focused on developing and commercializing transformative...

Cardinal Health completes sale of Cordis business to Hellman & Friedman
Corporate/ 2023-07-23
Cardinal Health completes sale of Cordis...

DUBLIN,Ohio,Aug. 2,2021--Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously a...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release